C5a Serum Levels in Patients with Endometriosis: A Cross-Sectional Study
article
OA: closed
CC0
AI-generated summary
Serum C5a levels were significantly higher in endometriosis patients compared to controls but showed no association with disease stage, symptoms, or infertility duration.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis (EM) is a gynecological disorder that presents significant immune dysregulation in its pathophysiology. Recent studies indicate that the Complement System may play a significant role in the immune processes involved in peritoneal clearance and inflammation in EM patients. C5a is a potent anaphylatoxin molecule of complement associated with the development of inflammatory disorders, however its possible impact on EM development requires further investigation. The aim of this study was to determine the concentration of serum C5a in women with EM and to investigate its possible association with severity, symptoms, age and the timing of infertility. Ninety-four patients with EM (from stage I to IV) and 50 healthy controls were assessed for C5a serum levels. Clinical and demographic data were included in the analysis. C5a serum levels were higher in patients with EM than in controls (39.5 ng/mL vs. 26.0 ng/mL; p < .0001), but not different between the EM stages. No association was observed between C5a serum concentration and the presence of symptoms, age, symptom time or infertility time. The C5a serum levels were higher in patients with EM than in controls but not associated with the severity or clinical findings.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (16)
- Altered Immunity in Endometriosis: What Came First? via openalex
- Endometriosis via openalex
- Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Treating endometriosis as an autoimmune disease via openalex
- W2617188474 via openalex
- W2768181046 via openalex
- W3019023274 via openalex
- W3088243710 via openalex
- W3112630471 via openalex
- W3120776825 via openalex
- W3124896344 via openalex
- W2141436010 via openalex
- W2109982451 via openalex
- W2159001526 via openalex
- W2266777592 via openalex
Source provenance
- europepmc
- last seen: 2026-09-10T06:15:44.054944+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-09-10T06:14:50.443701+00:00
- unpaywall
- last seen: 2026-09-10T06:36:06.991349+00:00
License: CC0
· commercial use OK